Olema Pharmaceuticals, Inc. SEC filings OLMA
Olema Pharmaceuticals, Inc. has 562 filings in SEC EDGAR's recent list, going back to Aug 27, 2018. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 16, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 3 | Initial insider ownership | Aug 13, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 144 | Notice of proposed sale | Jul 24, 2026 | — |
| 144 | Notice of proposed sale | Jul 23, 2026 | — |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 26, 2026 | May 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 1, 2026 | Apr 27, 2026 |
| 4 | Insider transaction | Apr 29, 2026 | Apr 28, 2026 |
| 3 | Initial insider ownership | Apr 29, 2026 | Apr 28, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 29, 2026 | Apr 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 20, 2026 | — |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| 144 | Notice of proposed sale | Mar 11, 2026 | — |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 6, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 144 | Notice of proposed sale | Feb 27, 2026 | — |
| 144 | Notice of proposed sale | Feb 24, 2026 | — |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 2, 2026 |
| 3 | Initial insider ownership | Feb 17, 2026 | Jan 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 144 | Notice of proposed sale | Feb 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 30, 2026 | Jan 27, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 20, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 15, 2026 | Jan 13, 2026 |
| 144 | Notice of proposed sale | Jan 15, 2026 | — |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 144 | Notice of proposed sale | Jan 14, 2026 | — |
| 144 | Notice of proposed sale | Jan 14, 2026 | — |
| 144 | Notice of proposed sale | Jan 13, 2026 | — |
| 144 | Notice of proposed sale | Jan 13, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 144 | Notice of proposed sale | Jan 12, 2026 | — |
| 4 | Insider transaction | Dec 30, 2025 | Dec 26, 2025 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 19, 2025 |
| 144 | Notice of proposed sale | Dec 23, 2025 | — |
| 144 | Notice of proposed sale | Dec 22, 2025 | — |
| 144 | Notice of proposed sale | Dec 22, 2025 | — |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| S-3ASR | Automatic shelf registration | Dec 11, 2025 | — |
| 4 | Insider transaction | Dec 9, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Other events
|
Nov 19, 2025 | Nov 19, 2025 |
| 424B5 | Prospectus supplement | Nov 19, 2025 | — |
| S-3MEF | Filing | Nov 18, 2025 | — |
| 424B5 | Prospectus supplement | Nov 18, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2025 | Oct 18, 2025 |
| 4 | Insider transaction | Sep 18, 2025 | Sep 16, 2025 |
| 144 | Notice of proposed sale | Sep 18, 2025 | — |
| 144 | Notice of proposed sale | Sep 16, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 13, 2025 | — |
| 4/A | Filing | May 13, 2025 | Dec 13, 2024 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Apr 28, 2025 |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 3 | Initial insider ownership | Feb 28, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| EFFECT | Filing | Jan 15, 2025 | — |
| EFFECT | Filing | Jan 15, 2025 | — |
| 424B5 | Prospectus supplement | Jan 15, 2025 | — |
| 424B3 | Prospectus | Jan 15, 2025 | — |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 8, 2025 |
| 3 | Initial insider ownership | Jan 13, 2025 | Jan 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jan 10, 2025 | Jan 10, 2025 |
| UPLOAD | Letter from the SEC | Jan 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2025 | — |
| S-3 | Shelf registration | Jan 6, 2025 | — |
| S-3 | Shelf registration | Jan 3, 2025 | — |
| 4/A | Filing | Dec 18, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 16, 2024 |
| 144 | Notice of proposed sale | Dec 13, 2024 | — |
| D | Filing | Dec 12, 2024 | — |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 144 | Notice of proposed sale | Dec 11, 2024 | — |
| 144 | Notice of proposed sale | Dec 11, 2024 | — |
| 144 | Notice of proposed sale | Dec 11, 2024 | — |
| 144 | Notice of proposed sale | Dec 11, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Dec 11, 2024 | — |
| 144 | Notice of proposed sale | Dec 11, 2024 | — |
| 144 | Notice of proposed sale | Dec 10, 2024 | — |
| 144 | Notice of proposed sale | Dec 10, 2024 | — |
| 144 | Notice of proposed sale | Dec 10, 2024 | — |
| 144 | Notice of proposed sale | Dec 10, 2024 | — |
| 144 | Notice of proposed sale | Dec 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 4, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 4, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 2, 2024 | Nov 29, 2024 |
| 4/A | Filing | Nov 26, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2024 | Sep 27, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 5, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 144 | Notice of proposed sale | Jul 30, 2024 | — |
| 144 | Notice of proposed sale | Jul 29, 2024 | — |
| 4 | Insider transaction | Jul 12, 2024 | Jul 11, 2024 |
| 144 | Notice of proposed sale | Jul 11, 2024 | — |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 2, 2024 | Jun 28, 2024 |
| 144 | Notice of proposed sale | Jun 28, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OLMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1750284
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.